ARS Pharmaceuticals

SPRY · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 20 days ago

Total Revenue

$28.1M

Previous year: $86.6M

Previous year: $35.5M

Loading...

ARS Pharmaceuticals

Unlock previous datapoints

Upgrade

ARS Pharmaceuticals

Unlock previous datapoints

Upgrade

ARS Pharmaceuticals Revenue by Segment

ARS Pharmaceuticals Revenue by Geographic Location

Revenue by Segment

U.S. Net Product Revenue

CapyFin.com

Collaboration Revenue

CapyFin.com

Supply Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$801M

P/E Ratio

-4.61

Sector

N/A

Industry

N/A

52-Week High

$18.3

52-Week Low

$6.72

R&D Expenses

$3.4M

SG&A Expenses

$60M

Prescribing HCPs

22.5K

Target Gross-to-Net

50%

Products

Get in Touch

Resources

ARS Pharmaceuticals

ARS Pharmaceuticals

ARS Pharmaceuticals

ARS Pharmaceuticals Revenue by Segment

ARS Pharmaceuticals Revenue by Geographic Location

Revenue by Segment

U.S. Net Product Revenue

Collaboration Revenue

Supply Revenue

Revenue by Geographic Location

United States Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics